Antihypertensive treatment in the elderly

Clinical and Experimental Hypertension

Volumn 18, Issue 3-4, 1996, Pages 435-447

  Lindholm, Lars H ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

cardiovascular; disease; drug therapy; health economy; hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT;

AGE; AGED; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; RISK FACTOR;

EID: 0029968225     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969609088975     Document Type: Conference Paper

References (33)

1. Kannel WB. Prevalence, incidence and hazards of hypertension in the elderly. Ger Cardiovasc Med 1988; 1:5-10.
2. Holme I, Waaler HT. Five-year mortality in the city of Bergen, Norway, according to age, sex and blood pressure. Acta Med Scand 1976;200:229-39.
3. Agner E. Predictive value of arterial blood pressures in old age. A ten-year prospective study of men and women born in 1897 and examined at the age of 70 and 80 years. Acta Med Scand 1983;214.285-94.
4. Fry J. Natural history of hypertension. A case for selective non-treatment. Lancet 1974;ii:431-3.
5. Mattila K, Haavisto M, Rajala S, Heikinheimo R. Blood pressure and five year survival in the very old. Br Med J 1988;296:887-9.
6. Anderson F, Cowan NR. Survival of healthy older people. Brit J prev soc Med 1976;30:231-2.
7. Landahl S, Lernfelt B, Sundh V. Blood pressure and mortality in old age. Eleven years' follow-up of a 70-year-old population. J Hypertension 1987;5.745-8.
8. Staessen J, Bulpitt C, Clement D, et al. Relation between mortality and treated blood pressure in elderly patient with hypertension: report of the European Working Party on High Blood Pressure in the Elderly. BMJ 1989;298:1552-6.
9. Coope J, Warrender TS, McPherson K. The prognostic significance of blood pressure in the elderly J Human Hypertension 1988;2:79-88.
10. Veterans Administration Cooperative Study Group on Anti-hypertensive Agents. Effects of treatment on morbidity in hypertension. III. Influence of age, diastolic blood pressure, and prior cardiovascular disease. Further analysis of side effects. Circulation 1972;45:991-1004.
11. Hypertension and Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979;242.2562-71.
12. Management Committee. Treatment of mild hypertension in the elderly. The National Heart Foundation of Australia. Med J Aust 1981;2:398-402.
13. Amery A, Birkenhäger W, Brixko P et al. Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet 1986;ii 589-92
14. Coope J, Warrender TS. Randomised trial of teatment of hypertension in elderly patients in primary care. BMJ 1986,293:1145-51.
15. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
16. Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;33-8:1281-5
17. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992,304:405-12.
18. Dahlöf B, Hansson L, Lindholm LH, Scherstén B, Wester PO, Ekbom T, Hedner T, de Faire U. STOP-Hypertension 2. A prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Blood Pressure 1993;2:136-41.
19. Cooper WD, Sheldon B, Brown D et al. Postmarketing surveillance of enalapril: Experience in 11,710 hypertensive patients in general practice. J R Coll Gen Pract August 1987
20. Chalmers JP, Smith SA, Wing LMH. Hypertension in the elderly. The role of calcium antagonists. J Cardiovasc Pharmacol 1988;12 (suppl 8):147-55.
21. Appelgate WB, Phillips HL, Schnapper H et al A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women Arch Intern Med 1991,151:1817-23.
22. Rizzini P, Castello C, Salvi S, Rechhia G. Efficacy and safety of lacidipine, a new long-lasting calcium antagonist, in elderly hypertensive patients. J Cardiovasc Pharmacol 1991; 17 (suppl 4):S38-S44.
23. Fletcher AE. Adverse treatment effects in the trial of the European Working Party on High Blood Pressure in the Elderly. Am J Med 1991;90(suppl 3A):S42-S44)
24. Ekbom T, Dahlöf B, Hansson L, Lindholm LH, Scherstén B, Wester PO. Antihypertensive efficacy and side-effects of three beta-blockers and a diuretic in elderly hypertensives - a report from the STOP-Hypertension Study J Hypertens 1992;10:1525-30.
25. Lindholm LH, Agenas I, Dahlgren H, de Faire U, Hjelmdahl P, Johannesson M et al. Måttligt förhöjt blodtryck. Stockholm The Swedish Council on Technology Assessment in Health Care; 1994, report 121 pp 1-249 (in Swedish). We will soon be able to change this reference to an English one
26. Weinstein MC, Zeckerhauser R. Critical ratios and efficient allocations J Public Economics 1973;2:147-57.
27. Stason WB, Weinstein MC. Allocation of resources to manage hypertension. N Engl J Med 1977;296.732-9.
28. Lindgren B, Persson B. The cost-effectiveness of a new antihypertensive drug: Doxazosin. Curr Ther Res 1989;45:738-60.
29. Edelson JT, Weinstein MC, Tosteson AN, Williams L, Lee TH, Goldman L. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA 1990;263:407-13.
30. Johannesson M, Jönsson B. Cost-effectiveness analysis of hypertension treatment: a review of methodological issues. Health Policy 1991,19;55-77.
31. MacMahon S, Peto R, Cutler J et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure, prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74
32. Colins R, Peto R, Mac Mahon S, Herbert P, Fiebach NH, Eberlein KA et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context Lancet 1990,335:827-38.
33. Johannesson M, Dahlöf B, Lindholm LH, Ekbom T, Hansson L, Odén A et al. Treatment of hypertension in the elderly is cost-effective - an analysis of the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). J Int Med 1993; 234:317-23.